- Report
- October 2023
- 80 Pages
Brazil
From €2507EUR$2,595USD£2,143GBP
- Report
- October 2023
- 80 Pages
Argentina
From €2507EUR$2,595USD£2,143GBP
- Report
- October 2023
- 80 Pages
Vietnam
From €2507EUR$2,595USD£2,143GBP
- Report
- October 2023
- 80 Pages
United States
From €2507EUR$2,595USD£2,143GBP
- Report
- October 2023
- 80 Pages
United Kingdom
From €2507EUR$2,595USD£2,143GBP
- Report
- October 2023
- 80 Pages
South Korea
From €2507EUR$2,595USD£2,143GBP
- Report
- October 2023
- 80 Pages
Russia
From €2507EUR$2,595USD£2,143GBP
- Report
- October 2023
- 80 Pages
Poland
From €2507EUR$2,595USD£2,143GBP
- Report
- October 2023
- 80 Pages
Japan
From €2507EUR$2,595USD£2,143GBP
- Report
- October 2023
- 80 Pages
Ireland
From €2507EUR$2,595USD£2,143GBP
- Report
- October 2023
- 80 Pages
China
From €2507EUR$2,595USD£2,143GBP
- Report
- October 2023
- 100 Pages
Africa
From €3666EUR$3,795USD£3,135GBP
- Report
- September 2023
- 38 Pages
Canada
From €845EUR$875USD£723GBP
- Report
- October 2020
- 87 Pages
Global
From €101EUR$105USD£87GBP
- Webinar
- June 2018
- 90 Minutes
Global
From €173EUR$179USD£148GBP
- Report
- April 2023
- 160 Pages
Global
From €5795EUR$5,999USD£4,955GBP
- Report
- June 2021
- 299 Pages
Global
From €5958EUR$6,168USD£5,095GBP
- Report
- March 2023
- 147 Pages
Global
From €5795EUR$5,999USD£4,955GBP
- Book
- August 2021
- 672 Pages
Schizophrenia is a mental disorder characterized by abnormal social behavior and a distorted perception of reality. It is one of the most disabling and emotionally devastating mental illnesses, affecting approximately 1% of the population worldwide. Symptoms of schizophrenia can include hallucinations, delusions, disorganized speech and behavior, and cognitive deficits.
The schizophrenia market within the context of mental health is a rapidly growing sector, driven by the increasing prevalence of the disorder and the need for better treatments. The market is expected to benefit from the development of novel drugs and therapies, as well as the increasing awareness of mental health issues. Additionally, the increasing focus on personalized medicine and the development of digital health technologies are expected to drive the market growth.
Some of the key players in the schizophrenia market include Eli Lilly, Johnson & Johnson, Novartis, Pfizer, Otsuka Pharmaceutical, Sunovion Pharmaceuticals, Allergan, and Merck. Show Less Read more